Originator Merck carried it through Phase 2 trials and a Phase 2b hip-fracture study but never filed for approval, so there is no FDA-approved prescription version
Relations of gut liver axis components and gut microbiota in obese children with fatty liver: a pilot study
The following source parameters were applied: capillary voltage (+4 kV), end plate offset (-500 V), nebulizer (30 psi), dry gas (8 L/min), dry temperature (300 C), skimmer (40 V), capillary exit (166 V)
Manufactured to the highest standards for researchers worldwide.
Systematic capture of dosing patterns, formulation source, route of administration, and standardized clinical outcomes may be more informative than continued reliance on heterogeneous mechanistic studies